K

Kronos Bio
D

KRON

0.99650
USD
-0.03
(-2.78%)
مغلق
حجم التداول
6,600
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
60,129,725
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AMWL
    -0.310
    (-2.60%)
    11.630 USD
    CVS
    CVS
    -1.595
    (-2.45%)
    63.495 USD
    G
    GNRC
    -0.450
    (-0.32%)
    138.090 USD
    RMD
    RMD
    -1.320
    (-0.57%)
    231.520 USD
    T
    TDOC
    -1.190
    (-9.38%)
    11.490 USD
    UNH
    UNH
    -36.64
    (-7.29%)
    465.92 USD
    W
    WBA
    -0.360
    (-3.43%)
    10.145 USD
    المزيد
الأخبار
المقالات

العنوان: Kronos Bio

القطاع: Healthcare
الصناعة: Biotechnology
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.